ClinicalTrials.govpublic full text
Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy
antineoplastic combined chemotherapy protocols, neoadjuvant chemotherapy, pegylated liposomal doxorubicin, breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 835675
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.